Legend Biotech (LEGN) Return on Invested Capital Growth (3y) (2023 - 2026)

Legend Biotech (LEGN) Return on Invested Capital Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 2.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Legend Biotech 7.11 Bn 6.46 Bn 129.70 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Sep 30, 2025 1.00
Jun 30, 2025 2.00
Mar 31, 2025 2.00
Dec 31, 2024 3.00
Sep 30, 2024 96.00
Jun 30, 2024 102.00
Mar 31, 2024 130.00
Dec 31, 2023 136.00
Sep 30, 2023 34.00
Jun 30, 2023 37.00